Filana Therapeutics, Inc.

Stock Chart, Company Information, and Scan Results

$1.25(as of Jun 12, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Filana Therapeutics, Inc. Company Information, Fundamentals, and Technical Indicators

Stock Price$1.25
Ticker SymbolFLNA
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees17
CountyUSA
Market Cap$60.4M
EBIDTA-48.7M
10-Day Moving Average1.37
P/E Ratio-0.78
20-Day Moving Average1.36
Forward P/E Ratio151.52
50-Day Moving Average1.47
Earnings per Share-1.61
200-Day Moving Average2.32
Profit Margin-Infinity%
RSI39.54
Shares Outstanding48.3M
ATR0.10
52-Week High4.98
Volume193,000
52-Week Low1.16
Most Recent Support Level1.29
Book Value68.1M
Most Recent Resistance Level1.50
P/B Ratio0.89
Upper Keltner1.58
P/S RatioInfinity
Lower Keltner1.14
Debt-to-Equity Ratio1.58
Next Earnings Date08/12/2026
Cash Surplus46.5M
Next Ex-Dividend DateUnknown

Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is in Phase 3 clinical trial to treat Alzheimer's disease; and investigational diagnostic product candidate is SavaDx, an early-stage program focused on detecting the presence of Alzheimer's disease from a small sample of blood. The company was formerly known as Cassava Sciences, Inc. and changed its name to Filana Therapeutics, Inc. in March 2026. The company was incorporated in 1998 and is based in Austin, Texas.

Filana Therapeutics, Inc. In Our Stock Scanner

As of Jun 15, 2026
example chart graphic
Scan Name: Low PB RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Bull FlagScan Type: Chart Pattern Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.